Epidemiological study of severe cutaneous adverse drug reactions in a city district of China

Clinical and Experimental Dermatology

Volumn 31, Issue 5, 2006, Pages 642-647

  Li, L F ^a   Ma, C ^a  

^a PEKING UNIVERSITY THIRD HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; CHINESE DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; CHINA; CHINESE MEDICINE; DISEASE SEVERITY; DRUG HYPERSENSITIVITY; DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOM; ECZEMA; EPILEPSY; ERYTHEMA MULTIFORME; EXFOLIATIVE DERMATITIS; FEMALE; HUMAN; INCIDENCE; INFECTION; LICHEN PLANUS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PAIN; PREVALENCE; PRIORITY JOURNAL; RASH; RETROSPECTIVE STUDY; SEVERE CUTANEOUS ADVERSE DRUG REACTION; SKIN MANIFESTATION; STEVENS JOHNSON SYNDROME; TOXIC EPIDERMAL NECROLYSIS; URTICARIA; VASCULITIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ANTICONVULSANTS; CHINA; DERMATITIS, EXFOLIATIVE; DRUG ERUPTIONS; EPIDERMAL NECROLYSIS, TOXIC; FEMALE; HUMANS; INCIDENCE; MALE; MEDICINE, CHINESE TRADITIONAL; MIDDLE AGED; RETROSPECTIVE STUDIES; STEVENS-JOHNSON SYNDROME;

EID: 33746122625     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2006.02185.x     Document Type: Article

References (16)

1. Pitche P, Padonou CS, Kombate K et al. Stevens-Johnson syndrome and toxic epidermal necrolysis in Lome (Togo). Evolutional and etiological profiles of 40 cases. Ann Dermatol Venereol 2005; 132: 531-4.
2. Ghislain PD, Roujeau JC. Treatment of severe drug reactions: Stevens-Johnson syndrome, toxic epidermal necrolysis and hypersensitivity syndrome. Dermatol Online J 2002; 8: 5.
3. Mittmann N, Knowles SR, Gomez M et al. Evaluation of the extent of under-reporting of serious adverse drug reactions: the case of toxic epidermal necrolysis. Drug Saf 2004; 27: 477-87.
4. Chan HL, Stern RS, Arndt KA et al. The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. A population-based study with particular reference to reactions caused by drugs among outpatients. Arch Dermatol 1990; 126: 43-7.
5. Schopf E, Stuhmer A, Rzany B et al. Toxic epidermal necrolysis and Stevens-Johnson syndrome. An epidemiologic study from West Germany. Arch Dermatol 1991; 127: 839-42.
6. Leenutaphong V, Sivayathorn A, Suthipinittharm P, Sunthonpalin P. Stevens-Johnson syndrome and toxic epidermal necrolysis in Thailand. Int J Dermatol 1993; 32: 428-31.
7. Yeung CK, Ma SY, Hon C et al. Aetiology in sixteen cases of toxic epidermal necrolysis and Stevens-Johnson syndrome admitted within eight months in a teaching hospital. Acta Derm Venereol 2003; 83: 179-82.
8. Roujeau JC, Kelly JP, Naldi L et al. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med 1995; 333: 1600-7.
9. Roujeau JC, Guillaume JC, Fahre JP et al. Toxic epidermal necrolysis (Lyell syndrome). Incidence and drug etiology in France, 1981-85. Arch Dermatol 1990; 126: 37-42.
10. Zhang X. ADR reporting is extremely low in China. Beijing Evening Newspaper, 23,April 2005.
11. Li Q, Zhang SM, Chen HT et al. Study on the knowledge and attitude to adverse drug reactions reporting among healthcare professionals in Wuhan city. Zhonghua Liu Xing Bing Xue Za Zhi 2004; 25: 894-7.
12. World Health Organization. International Drug Monitoring. The Role of the Hospital. Technique series no. 425. Geneva, Switzerland: World Health Organization, 1966.
13. Stern RS, Wintroub BU, et al. In: Fitzpatrick's Dermatology in General Medicine, 5th ed (Freedberg IM, Eisen AZ, Wolff K et al., eds.) New York: McGraw-Hill, 1999; 1633-42.
14. Fiszenson-Albala F, Auzerie V, Mahe E et al. Epidemiology and health services research. A 6-month prospective survey of cutaneous drug reactions in a hospital setting. Br J Dermatol 2003; 149: 1018-22.
15. Dasgupta A. Review of abnormal laboratory test results and toxic effects due to use of herbal medicines. Am J Clin Pathol 2003; 120: 127-37.
16. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drugs reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998; 279: 1200-5.